ALHC insider plans sale of 596,000 shares

A selling holder has filed a notice to sell up to 596,000 shares of ALHC common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

A selling holder has filed a notice to sell up to 596,000 shares of ALHC common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The proposed sale has an aggregate value of $12,533,880.00, with ALHC common stock listed on NASDAQ. ALHC had 206,733,823 shares of common stock outstanding as of this notice, which is a baseline figure, not the amount being sold. In the past three months, the same plan sold shares on three dates with specified share amounts and proceeds.

Key Figures

Planned shares to be sold: 596,000 shares Proposed aggregate sale price: $12,533,880.00 Shares outstanding: 206,733,823 shares +3 more

6 metrics

Planned shares to be sold 596,000 shares Common stock proposed for sale under the notice

Proposed aggregate sale price $12,533,880.00 Total value of the 596,000 shares of common stock

Shares outstanding 206,733,823 shares ALHC common stock outstanding as referenced in the notice

Sale on 06/10/2026 298,000 shares; $6,066,624.40 Common stock sold under 10b5-1 sales plan

Sale on 05/11/2026 298,000 shares; $5,032,862.40 Common stock sold under 10b5-1 sales plan

Sale on 04/13/2026 82,299 shares; $1,711,654.60 Common stock sold under 10b5-1 sales plan

Key Terms

Form 144, 10b5-1 Sales Plan, pre-IPO

3 terms

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road"

A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.

pre-IPO financial

"Shares Issued Pre-IPO in exchange for Partnership Units | Issuer"

Pre-IPO describes the stage when a privately held company offers shares or commitments to investors before its initial public offering. For investors, pre-IPO deals can provide a chance to buy equity at lower prices—like getting into a house before it goes on the market—but they come with higher uncertainty, limited ability to sell quickly, and the risk that the public listing may be delayed, changed, or never occur.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ALHC Form 144 notice disclose about planned share sales?

The notice discloses an intention to sell up to 596,000 shares of ALHC common stock, with a proposed aggregate sale price of $12,533,880.00, through Morgan Stanley Smith Barney LLC.

How many ALHC shares are outstanding in the Form 144 notice?

The notice states that ALHC has 206,733,823 shares of common stock outstanding. This figure provides context for the planned sale and is not the amount being sold.

What ALHC shares were sold under the 10b5-1 plan in the last three months?

Under the 10b5-1 sales plan, sales included 298,000 shares on 06/10/2026, 298,000 shares on 05/11/2026, and 82,299 shares on 04/13/2026, each with specified proceeds in dollars.

Who is involved in executing the ALHC share sales in the Form 144 notice?

The planned sale of 596,000 ALHC shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, acting from its New York office listed in the notice.

What is the proposed aggregate dollar value of ALHC shares to be sold?

The proposed aggregate sale price for the planned 596,000 ALHC shares is listed as $12,533,880.00, based on the information in the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/10/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222028
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALIGNMENT HEALTHCARE INC
SEC File Number	001-40295
Address of Issuer	1100 W. Town and Country Road Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	JEK TRUST U/A DTD 02/08/2021
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	596000	12533880.00	206733823	07/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2014	Shares Issued Pre-IPO in exchange for Partnership Units	Issuer			596000	05/09/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	06/10/2026	298000	6066624.40
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	05/11/2026	298000	5032862.40
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	04/13/2026	82299	1711654.60

144: Remarks and Signature

Remarks	The securities to be sold were Shares Issued Pre-IPO in exchange for Partnership Units during the period of 05/09/2014 through 09/07/2025.
Date of Notice	07/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Kao
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)